We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Former FDA Official Asks Generic Industry to Support User Fees
Former FDA Official Asks Generic Industry to Support User Fees
March 30, 2007
Federal policymakers should ensure the FDA has adequate resources to review and approve follow-on biologics in a timely and effective manner, according to American Enterprise Institute (AEI) Research Fellow Scott Gottlieb.